FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2784637237> ?p ?o ?g. }

• W2784637237 abstract "High frequency of recurrence is the major cause of the poor outcomes for patients with hepatocellular carcinoma (HCC). microRNA (miR)-182-5p emerged as a high-priority miRNA in HCC and was found to be related to HCC metastasis. Whether the expression of miR-182-5p in tumor tissue correlated with early recurrence in HCC patients underwent curative surgery was unknown. Real-time PCR (RT-PCR) and in situ hybridization (ISH) were conducted to assess the expression of miR-182-5p in HCC cells and tissues. Cell Counting Kit-8 (CCK-8), transwell assays were performed to detected cells proliferation and migration ability. Flow cytometry assays were used to detect cell apoptosis rate, and xenograft model was employed to study miR-182-5p in HCC growth and lung metastasis. The target of miR-182-5p was validated with a dual-luciferase reporter assay and western blotting. Immunohistochemistry, immumoblotting, and immunoprecipitation were performed to test relative protein expression. We showed that high expression of miR-182-5p in tumor tissues correlated with poor prognosis as well as early recurrence in HCC patients underwent curative surgery. miR-182-5p enhanced motility and invasive ability of HCC cells both in vitro and in vivo. miR-182-5p directly targets 3′-UTR of FOXO3a and repressed FOXO3a expression, activating AKT/FOXO3a pathway to promote HCC proliferation. Notably, miR-182-5p activated Wnt/β-catenin signaling by inhibiting the degradation of β-catenin and enhancing the interaction between β-catenin and TCF4 which was mediated by repressed FOXO3a. Consistently, miR-182-5p can be a potential predictor of early recurrence for HCC patients underwent curative surgery, and FOXO3a plays a key mediator in miR-182-5p induced HCC progression." @default.
• W2784637237 created "2018-02-02" @default.
• W2784637237 creator A5002188808 @default.
• W2784637237 creator A5002439727 @default.
• W2784637237 creator A5002708668 @default.
• W2784637237 creator A5005888513 @default.
• W2784637237 creator A5008854792 @default.
• W2784637237 creator A5014644502 @default.
• W2784637237 creator A5017352295 @default.
• W2784637237 creator A5023061114 @default.
• W2784637237 creator A5032426914 @default.
• W2784637237 creator A5042536439 @default.
• W2784637237 creator A5044670575 @default.
• W2784637237 creator A5056338205 @default.
• W2784637237 creator A5058898797 @default.
• W2784637237 creator A5067973918 @default.
• W2784637237 creator A5073847826 @default.
• W2784637237 creator A5074008217 @default.
• W2784637237 creator A5079615657 @default.
• W2784637237 creator A5083691374 @default.
• W2784637237 creator A5090826689 @default.
• W2784637237 date "2018-01-24" @default.
• W2784637237 modified "2023-10-18" @default.
• W2784637237 title "miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a" @default.
• W2784637237 cites W1184375026 @default.
• W2784637237 cites W144423133 @default.
• W2784637237 cites W1880424969 @default.
• W2784637237 cites W1966828006 @default.
• W2784637237 cites W1983142022 @default.
• W2784637237 cites W1984009107 @default.
• W2784637237 cites W1997075641 @default.
• W2784637237 cites W2000288497 @default.
• W2784637237 cites W2007530728 @default.
• W2784637237 cites W2009102003 @default.
• W2784637237 cites W2056353125 @default.
• W2784637237 cites W2057247058 @default.
• W2784637237 cites W2057929910 @default.
• W2784637237 cites W2059357290 @default.
• W2784637237 cites W2062429284 @default.
• W2784637237 cites W2064027874 @default.
• W2784637237 cites W2073952925 @default.
• W2784637237 cites W2079797384 @default.
• W2784637237 cites W2088442622 @default.
• W2784637237 cites W2092780583 @default.
• W2784637237 cites W2100082824 @default.
• W2784637237 cites W2102942095 @default.
• W2784637237 cites W2122724788 @default.
• W2784637237 cites W2129361678 @default.
• W2784637237 cites W2132054434 @default.
• W2784637237 cites W2133098474 @default.
• W2784637237 cites W2138583492 @default.
• W2784637237 cites W2148923243 @default.
• W2784637237 cites W2155507705 @default.
• W2784637237 cites W2159659581 @default.
• W2784637237 cites W2161145604 @default.
• W2784637237 cites W2164356078 @default.
• W2784637237 cites W2169835628 @default.
• W2784637237 cites W2170618275 @default.
• W2784637237 cites W2197266972 @default.
• W2784637237 cites W2236563308 @default.
• W2784637237 cites W2278107767 @default.
• W2784637237 cites W2295189237 @default.
• W2784637237 cites W2476478196 @default.
• W2784637237 cites W2551363196 @default.
• W2784637237 cites W2917837889 @default.
• W2784637237 cites W326741768 @default.
• W2784637237 doi "https://doi.org/10.1186/s13045-018-0555-y" @default.
• W2784637237 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5782375" @default.
• W2784637237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29361949" @default.
• W2784637237 hasPublicationYear "2018" @default.
• W2784637237 type Work @default.
• W2784637237 sameAs 2784637237 @default.
• W2784637237 citedByCount "133" @default.
• W2784637237 countsByYear W27846372372018 @default.
• W2784637237 countsByYear W27846372372019 @default.
• W2784637237 countsByYear W27846372372020 @default.
• W2784637237 countsByYear W27846372372021 @default.
• W2784637237 countsByYear W27846372372022 @default.
• W2784637237 countsByYear W27846372372023 @default.
• W2784637237 crossrefType "journal-article" @default.
• W2784637237 hasAuthorship W2784637237A5002188808 @default.
• W2784637237 hasAuthorship W2784637237A5002439727 @default.
• W2784637237 hasAuthorship W2784637237A5002708668 @default.
• W2784637237 hasAuthorship W2784637237A5005888513 @default.
• W2784637237 hasAuthorship W2784637237A5008854792 @default.
• W2784637237 hasAuthorship W2784637237A5014644502 @default.
• W2784637237 hasAuthorship W2784637237A5017352295 @default.
• W2784637237 hasAuthorship W2784637237A5023061114 @default.
• W2784637237 hasAuthorship W2784637237A5032426914 @default.
• W2784637237 hasAuthorship W2784637237A5042536439 @default.
• W2784637237 hasAuthorship W2784637237A5044670575 @default.
• W2784637237 hasAuthorship W2784637237A5056338205 @default.
• W2784637237 hasAuthorship W2784637237A5058898797 @default.
• W2784637237 hasAuthorship W2784637237A5067973918 @default.
• W2784637237 hasAuthorship W2784637237A5073847826 @default.
• W2784637237 hasAuthorship W2784637237A5074008217 @default.
• W2784637237 hasAuthorship W2784637237A5079615657 @default.
• W2784637237 hasAuthorship W2784637237A5083691374 @default.
• W2784637237 hasAuthorship W2784637237A5090826689 @default.
• W2784637237 hasBestOaLocation W27846372371 @default.

• next